Jörgen Kristensen - Concepedia

Author

Jörgen Kristensen

Also Known As

J Kristensen, J. (b) Kristensen, J. B. Kristensen, J. Kristensen, J??rgen Kristensen, Jorgen Kristensen, JØRGEN KRISTENSEN, Jörgen Kristensen, Jørgen Kristensen

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Uppsala University Hospital Tawam Hospital United Arab Emirates University Uppsala University Leo Pharma (Denmark)

About

Jörgen Kristensen is an author at Uppsala University Hospital specializing in medicine, cancer research, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	21	747
2	Health Sciences	6	6	113
3	Engineering	1	1	54
4	Public Health	1	1	12
5	Biomedical Engineering	1	1	54

Jörgen Kristensen

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Laboratory determination of chemotherapeutic drug resistance in tumor cells from patients with leukemia, using a fluorometric microculture cytotoxicity assay (FMCA) Rolf Larsson, Jörgen Kristensen, Charlotta Sandberg, International Journal of Cancer	1992	246
Clinical Experience with Recombinant Factor VIla in Patients with Thrombocytopenia Jörgen Kristensen, A. Killander, Erik Hippe, Pathophysiology of Haemostasis and Thrombosis ImmunologyCoagulation MechanismPathologyInflammationThrombosis	1996	189
Assessment of the clinical utility of serial β-d-glucan concentrations in patients with persistent neutropenic fever Michael Ellis, Basel K. al-Ramadi, Malcolm Finkelman, Journal of Medical Microbiology	2008	130
Platelet Concentrates in an Additive Solution Prepared from Pooled Buffy Coats Lars Eriksson, Agneta Shanwell, H. Gulliksson, Vox Sanguinis Platelet-additive SolutionThrombosisPooled Buffy CoatsHematologyPlatelet Concentrates	1993	81
Detection of tumor‐specific cytotoxic drug activity <i>IN VITRO</i> using the fluorometric microculture cytotoxicity assay and primary cultures of tumor cells from patients Peter Nygren, H Fridborg, K Csóka, International Journal of Cancer	1994	80
Feasibility of the fluorometric microculture cytotoxicity assay (FMCA) for cytotoxic drug sensitivity testing of tumor cells from patients with acute lymphoblastic leukemia. Peter Nygren, Jörgen Kristensen, Bertil Jönsson, PubMed	1992	63
Prospective evaluation of mannan and anti-mannan antibodies for diagnosis of invasive Candida infections in patients with neutropenic fever Michael Ellis, Basel K. al-Ramadi, Roos Bernsen, Journal of Medical Microbiology	2009	62
Recombinant human interleukin 11 and bacterial infection in patients with haemological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial Michael Ellis, F. Zwaan, Ulla Hedström, The Lancet Bacterial InfectionMedicineMalignant Blood DisorderMetronomic TherapyImmunology	2003	55
Evaluation of Platelet Function Using the in vitro Bleeding Time and Corrected Count Increment of Transfused Platelets: Comparison between Platelet Concentrates Derived from Pooled Buffy Coates and Apheresis Lars Eriksson, Jörgen Kristensen, Karin Olsson, Vox Sanguinis EngineeringVitro Bleeding TimeBiomedical EngineeringThrombosisPlatelet Concentrates	1996	54
The cytotoxic activity of Taxol in primary cultures of tumour cells from patients is partly mediated by Cremophor EL Peter Nygren, K Csóka, Bertil Jönsson, British Journal of Cancer Tumor BiologyOncogenic AgentMedicinePrimary CulturesCremophor El	1995	45

Page 1